Paper · 20161663
References193
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 193
Download this page as JSON| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17,328,676 | Molecular mechanisms of antibody somatic hypermutation. | Annu Rev Biochem | 2007 | https://conductscience.org/library/papers/17328676 | PubMed |
| 2 | 1,827,140 | Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. | J Exp Med | 1991 | https://conductscience.org/library/papers/1827140 | PubMed |
| 3 | 16,709,796 | Space, selection, and surveillance: setting boundaries with BLyS. | J Immunol | 2006 | https://conductscience.org/library/papers/16709796 | PubMed |
| 4 | 15,502,841 | Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. | Nat Med | 2004 | https://conductscience.org/library/papers/15502841 | PubMed |
| 5 | 19,194,545 | Successful renal transplantation with desensitization in highly sensitized patients: a single center experience. | J Korean Med Sci | 2009 | https://conductscience.org/library/papers/19194545 | PubMed |
| 6 | 11,228,414 | Selection events operating at various stages in B cell development. | Curr Opin Immunol | 2001 | https://conductscience.org/library/papers/11228414 | PubMed |
| 7 | 19,100,397 | High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis. | Transplant Proc | 2008 | https://conductscience.org/library/papers/19100397 | PubMed |
| 8 | 17,496,547 | Rituximab therapy for acute humoral rejection after kidney transplantation. | Transplantation | 2007 | https://conductscience.org/library/papers/17496547 | PubMed |
| 9 | 16,508,933 | Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. | Arthritis Rheum | 2006 | https://conductscience.org/library/papers/16508933 | PubMed |
| 10 | 17,450,373 | Current concepts and perspectives of immunosuppression in organ transplantation. | Langenbecks Arch Surg | 2007 | https://conductscience.org/library/papers/17450373 | PubMed |
| 11 | 18,774,927 | Emerging role of Alemtuzumab in renal and renal-pancreas transplantation. | Expert Opin Biol Ther | 2008 | https://conductscience.org/library/papers/18774927 | PubMed |
| 12 | 17,229,080 | Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. | Am J Transplant | 2007 | https://conductscience.org/library/papers/17229080 | PubMed |
| 13 | 18,668,213 | Homeostatic control of B lymphocyte subsets. | Immunol Res | 2008 | https://conductscience.org/library/papers/18668213 | PubMed |
| 14 | 18,786,258 | Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. | Arthritis Res Ther | 2008 | https://conductscience.org/library/papers/18786258 | PubMed |
| 15 | 19,186,223 | Critical analysis of rituximab-induced serological changes in connective tissue diseases. | Autoimmun Rev | 2009 | https://conductscience.org/library/papers/19186223 | PubMed |
| 16 | 47,889 | Evidence for the clonal abortion theory of B-lymphocyte tolerance. | J Exp Med | 1975 | https://conductscience.org/library/papers/47889 | PubMed |
| 17 | 11,520,463 | TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. | Immunity | 2001 | https://conductscience.org/library/papers/11520463 | PubMed |
| 18 | 19,001,814 | Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. | Contrib Nephrol | 2009 | https://conductscience.org/library/papers/19001814 | PubMed |
| 19 | 19,519,810 | A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy. | Am J Transplant | 2009 | https://conductscience.org/library/papers/19519810 | PubMed |
| 20 | 16,796,719 | Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. | Am J Transplant | 2006 | https://conductscience.org/library/papers/16796719 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/20161663/references